 "Hikal soars as USFDA issues 'Zero' 483 observations for Bangalore facility")
Hikal soared 18% to Rs 257, also its record high on the National Stock Exchange (NSE) after the US healthy regulator issued ‘’zero” 483 observations for the company’s facility located at Bangalore.
The pharmaceutical company said that its active pharmaceutical ingredient (API) and intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the United State Food and Drug Administration (US FDA) in compliance with their requirements.
“At the end of the successful inspection, we have been informed by the Investigator that ''zero'' 483 observations were issued. This was a routine inspection by the US FDA”, Hikal said in a regulatory filing.
At 02:57 pm; the stock was up 13% at Rs 246 on the NSE. The trading volumes on the counter jumped more than 10-fold with a combined 1.11 million shares changed hands on the NSE and BSE so far.
The pharmaceutical company said that its active pharmaceutical ingredient (API) and intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the United State Food and Drug Administration (US FDA) in compliance with their requirements.
“At the end of the successful inspection, we have been informed by the Investigator that ''zero'' 483 observations were issued. This was a routine inspection by the US FDA”, Hikal said in a regulatory filing.
At 02:57 pm; the stock was up 13% at Rs 246 on the NSE. The trading volumes on the counter jumped more than 10-fold with a combined 1.11 million shares changed hands on the NSE and BSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%